Your prediction
Valbiotis Stock
Valbiotis dominated the market today, gaining €0.090 (9.740%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Valbiotis stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Valbiotis in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Valbiotis vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Valbiotis | 9.740% | - | - | - | - | - | - |
| Sensorion SA | -33.820% | -42.529% | 30.293% | - | - | - | - |
| Cerenis Therapeutics Holding S.A. | -1.450% | -6.707% | -7.692% | 147.173% | -10.787% | 44.340% | 234.426% |
| Genoway S.A. Inh. | 0.880% | 2.232% | -1.717% | -30.606% | -7.661% | -38.024% | -35.674% |
News
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
